MERUS N.V. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 45.04 USD | +0.24% |
|
+13.14% | +63.78% |
| Apr. 19 | Gilead Sciences Likely to Record IPR&D Hit on Q1 Non-GAAP Earnings, Oppenheimer Says | MT |
| Mar. 28 | Truist Securities Initiates Coverage on Merus With Buy Rating, $69 Price Target | MT |
Valuation
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 406.5 | 509.9 | 1,357 | 716.3 | 1,588 | 2,643 | - | - |
| Enterprise Value (EV) 1 | 166.7 | 509.9 | 1,357 | 716.3 | 1,588 | 2,643 | 2,643 | 2,643 |
| P/E ratio | -6.18 x | -6 x | -18.4 x | -5.3 x | -9.17 x | -13.9 x | -13 x | -13.7 x |
| Yield | - | - | - | - | - | - | - | - |
| Capitalization / Revenue | 13.1 x | 17 x | 27.6 x | 17.2 x | 36.1 x | 69 x | 48.1 x | 33.1 x |
| EV / Revenue | 13.1 x | 17 x | 27.6 x | 17.2 x | 36.1 x | 69 x | 48.1 x | 33.1 x |
| EV / EBITDA | -7.07 x | - | -15.3 x | -4.5 x | -10.3 x | -13.8 x | -15 x | -25.2 x |
| EV / FCF | -6.23 x | -6.28 x | -22.4 x | -4.55 x | -10.9 x | -15.3 x | -13.9 x | -14.9 x |
| FCF Yield | -16.1% | -15.9% | -4.46% | -22% | -9.21% | -6.52% | -7.17% | -6.7% |
| Price to Book | 3.1 x | - | - | - | - | - | - | - |
| Nbr of stocks (in thousands) | 28,870 | 29,089 | 42,672 | 46,303 | 57,733 | 58,688 | - | - |
| Reference price 2 | 14.08 | 17.53 | 31.80 | 15.47 | 27.50 | 45.04 | 45.04 | 45.04 |
| Announcement Date | 3/12/20 | 3/16/21 | 2/28/22 | 2/28/23 | 2/28/24 | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 31.13 | 29.94 | 49.11 | 41.59 | 43.95 | 38.33 | 54.99 | 79.85 |
| EBITDA 1 | -57.52 | - | -88.73 | -159.1 | -154.2 | -192 | -176.1 | -104.9 |
| EBIT 1 | -58.66 | -75.88 | -89.98 | -160 | -156.5 | -198.6 | -217.2 | -223.1 |
| Operating Margin | -188.41% | -253.41% | -183.22% | -384.84% | -356.22% | -518.08% | -394.95% | -279.43% |
| Earnings before Tax (EBT) 1 | -54.96 | -85.01 | -66.58 | -130.2 | -151.7 | -181.6 | -209 | -214 |
| Net income 1 | -55.15 | -85.51 | -66.82 | -131.2 | -154.9 | -190.8 | -222.2 | -227.2 |
| Net margin | -177.15% | -285.59% | -136.06% | -315.48% | -352.56% | -497.86% | -404.16% | -284.53% |
| EPS 2 | -2.280 | -2.920 | -1.730 | -2.920 | -3.000 | -3.230 | -3.461 | -3.297 |
| Free Cash Flow 1 | -65.27 | -81.19 | -60.5 | -157.5 | -146.2 | -172.3 | -189.6 | -177.2 |
| FCF margin | -209.65% | -271.14% | -123.19% | -378.7% | -332.65% | -449.38% | -344.78% | -221.86% |
| FCF Conversion (EBITDA) | - | - | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - | - | - |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Announcement Date | 3/12/20 | 3/16/21 | 2/28/22 | 2/28/23 | 2/28/24 | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 13.67 | 14.71 | 11.66 | 12.68 | 6.581 | 10.67 | 13.5 | 10.48 | 11.03 | 8.939 | 8.342 | 7.988 | 8.61 | 8.089 | 6.078 |
| EBITDA 1 | - | - | - | - | - | - | - | - | - | -46.97 | -47.4 | -46.89 | -43.94 | -41.7 | - |
| EBIT 1 | -22.52 | -22.86 | -27.07 | -31.11 | -48.2 | -53.66 | -36.75 | -33.88 | -38.37 | -47.54 | -47.86 | -50.99 | -53.16 | -56.41 | - |
| Operating Margin | -164.75% | -155.45% | -232.29% | -245.25% | -732.34% | -503.12% | -272.26% | -323.45% | -347.76% | -531.85% | -573.72% | -638.34% | -617.45% | -697.41% | - |
| Earnings before Tax (EBT) 1 | -14.86 | -14.28 | -18.78 | -5.583 | -24.29 | -81.58 | -40.2 | -30.54 | -21.89 | -59.12 | -44.38 | -48.13 | -50.36 | -53.67 | - |
| Net income 1 | -14.85 | -14.42 | -18.89 | -5.714 | -24.62 | -81.97 | -39.74 | -32.03 | -23.01 | -60.15 | -45.03 | -48.68 | -52.06 | -56.03 | - |
| Net margin | -108.66% | -98.04% | -162.1% | -45.05% | -374.03% | -768.54% | -294.4% | -305.78% | -208.57% | -672.93% | -539.74% | -609.44% | -604.64% | -692.68% | - |
| EPS 2 | -0.3900 | -0.3400 | -0.4300 | -0.1300 | -0.5300 | -1.810 | -0.8600 | -0.6600 | -0.4300 | -1.090 | -0.7918 | -0.8473 | -0.8964 | -0.9482 | -0.8900 |
| Dividend per Share 2 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Announcement Date | 11/2/21 | 2/28/22 | 5/9/22 | 8/8/22 | 11/3/22 | 2/28/23 | 5/4/23 | 8/7/23 | 11/2/23 | 2/28/24 | - | - | - | - | - |
1USD in Million2USD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net Debt | - | - | - | - | - | - | - | - |
| Net Cash position | 240 | - | - | - | - | - | - | - |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - | - | - |
| Free Cash Flow 1 | -65.3 | -81.2 | -60.5 | -157 | -146 | -172 | -190 | -177 |
| ROE (net income / shareholders' equity) | - | - | -31.9% | -46.6% | -51.4% | -62.5% | -73.6% | -49.2% |
| ROA (Net income/ Total Assets) | - | - | - | - | - | - | - | - |
| Assets 1 | - | - | - | - | - | - | - | - |
| Book Value Per Share | 4.550 | - | - | - | - | - | - | - |
| Cash Flow per Share | -2.600 | - | - | - | - | - | - | - |
| Capex 1 | 2.22 | 1.29 | 0.87 | 7.59 | 3.98 | 5.27 | 5.94 | 6.51 |
| Capex / Sales | 7.14% | 4.3% | 1.77% | 18.24% | 9.06% | 13.74% | 10.8% | 8.15% |
| Announcement Date | 3/12/20 | 3/16/21 | 2/28/22 | 2/28/23 | 2/28/24 | - | - | - |
1USD in Million
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
13
Last Close Price
45.04
USD
Average target price
60.45
USD
Spread / Average Target
+34.22%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +63.78% | 2.64B | |
| -2.31% | 103B | |
| +0.56% | 95.28B | |
| +1.69% | 22.15B | |
| -17.37% | 21.02B | |
| -9.30% | 18.15B | |
| -41.01% | 16.73B | |
| -14.85% | 16.05B | |
| +3.21% | 13.68B | |
| +33.54% | 12.17B |
- Stock Market
- Equities
- MRUS Stock
- Financials Merus N.V.
